EP1713477
Samsetning á vorikónasóli og sveppalyfs CYP2C19 tálma.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
13.1.2005EP published:
1.10.2008EP application number:
05702261.8
EP translation filed:
28.10.2008Grant published:
15.11.2008EPO information:
European Patent Register
Max expiry date:
12.1.2025Expiry date:
31.1.2010
Title:
COMBINATION OF VORICONAZOLE AND AN ANTIFUNGAL CYP2C19 INHIBITOR
Timeline
Today
13.1.2005EP application
1.10.2008EP Publication
28.10.2008Translation submitted
15.11.2008Registration published
31.1.2010Expires
Owner
Name:
Pfizer Inc.Address:
235 East 42nd Street, New York NY 10017, US
Inventor
Name:
HUMPHREY, Michael JohnAddress:
Sandwich,Kent CT13 9NJ, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
0402491Date:
4.2.2004Country:
GB
Number:
545663 PDate:
17.2.2004Country:
US
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 3.11.2008
Expires: 31.1.2010
Payer: